Acme United Q1 sales up 14% to $52.3M; net income down 40% to $1.0M on tariff costs

ACME UNITED CORP

2026-Q1 EPS reported $0.24 revenue$52,301,000

Net income $1.0M ($0.24 diluted EPS) vs $1.7M ($0.41) YoY, down 40% and 41% respectively.
Gross margin improved to 39.7% from 39.0%; tariff-related costs and Med-Nap quality protocols pressured earnings.
My Medic acquisition (closed Jan 2026) added sales but minimal Q1 profit; expects majority of its profitability in Q4.
Company added ~$10M of incremental inventory orders for H2 2026 due to Iran conflict supply concerns.
Bank debt less cash rose to $38.6M from $27.2M; spent $14.6M on My Medic and $1.6M on German cutting line.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

ACME UNITED CORP reported the quarter ended March 31, 2026 results: revenue $52.3 million, net income $1.0 million, EPS $0.24 per diluted share.

Period: the quarter ended March 31, 2026
Revenue: $52.3 million
Net income: $1.0 million
EPS: $0.24 per diluted share
Result: reported results

Exact text from the filing

2026 FINANCIAL RESULTS SHELTON, CT – April 23, 2026 – Acme United Corporation (NYSE American: ACU) today announced that net sales for the quarter ended March 31, 2026 were $52.3 million compared to $46.0 million for the quarter ended March 31, 2025, an increase of 14%. Excluding incremental sales resulting from the acquisition of the assets of My Medic on

View on SEC.gov

1341 earnings releases filed in the last 30 days. Browse all earnings releases →

ACME UNITED CORP filing history →

Source: SEC EDGAR

accession 0001193125-26-172010

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.